척추성형술 및 경피적풍선척추성형술용 바늘 시장 : 제품 유형별, 소재별, 바늘 팁 유형별, 사용성별, 최종 사용자별, 유통 채널별 - 세계 시장 예측(2026-2032년)

The Vertebroplasty & Kyphoplasty Needles Market is projected to grow by USD 2.11 billion at a CAGR of 8.74% by 2032.

The vertebroplasty and kyphoplasty needles market is anchored in the clinical need to treat painful vertebral compression fractures caused by osteoporosis, trauma, and metastatic disease. These minimally invasive spine procedure devices enable controlled access to the vertebral body for bone cement delivery, making them essential components of vertebral augmentation systems used by interventional radiologists, spine surgeons, neurosurgeons, and orthopedic specialists.

Demand is supported by well-documented demographic and disease trends. The International Osteoporosis Foundation reports that osteoporosis causes more than 8.9 million fractures annually worldwide, and the United Nations projects sustained growth in the population aged 65 years and older through 2050. As hospitals and ambulatory surgery centers prioritize shorter procedures, improved imaging compatibility, and predictable cement delivery, vertebroplasty needles and kyphoplasty needles remain strategically important in minimally invasive spine care.

Transformative Shifts in Vertebral Augmentation Procedures

The market is shifting from procedure-enabling access devices toward precision-engineered vertebral augmentation tools designed for safety, workflow efficiency, and compatibility with advanced imaging environments. Clinicians increasingly seek needles with optimized bevel geometry, radiopaque visibility, ergonomic handles, and reliable cement flow control to support consistent performance in osteoporotic bone.

Healthcare systems are also moving care pathways toward evidence-guided patient selection, multidisciplinary fracture management, and value-based purchasing. These shifts favor manufacturers that can demonstrate procedural reliability, support training, and integrate their needles with cement systems, balloons, cannulas, and imaging-guided workflows.

Cumulative Impact of AI on Vertebroplasty and Kyphoplasty Needles

Artificial intelligence is beginning to influence the vertebroplasty and kyphoplasty needle ecosystem by improving diagnosis, procedural planning, and workflow standardization. AI-enabled imaging tools can help identify vertebral compression fractures on CT, MRI, and X-ray studies, supporting earlier referral for appropriate patients while reducing missed incidental fractures.

The cumulative impact is expected to be strongest in pre-procedure planning, navigation support, inventory optimization, and post-market surveillance. For device manufacturers, AI creates opportunities to pair vertebral augmentation needles with digital training, case analytics, and quality monitoring platforms that help clinicians improve consistency without replacing clinical judgment.

Key Regional Insights Across Global Spine Care Markets

North America remains a leading region for vertebroplasty and kyphoplasty needles due to established interventional radiology and spine surgery infrastructure, high osteoporosis screening awareness, and broad access to advanced imaging. Europe benefits from aging populations, formal fracture liaison services in several countries, and strong medical device regulatory oversight, while Asia-Pacific is expanding as China, India, Japan, South Korea, and Australia invest in hospital capacity, image-guided intervention, and minimally invasive spine care.

Latin America shows growing adoption in Brazil and Mexico as specialist access and private hospital networks expand. The Middle East, particularly GCC countries, is supported by investment in tertiary care, advanced imaging, and medical tourism, while Africa remains earlier in adoption, with demand concentrated in urban referral hospitals where CT, fluoroscopy access, and trained spine or interventional specialists are available.

Key Group Insights for Strategic Market Positioning

ASEAN markets are gaining relevance as hospital modernization, medical tourism, and orthopedic service expansion improve access to vertebral augmentation procedures. The GCC is characterized by high healthcare investment, advanced private hospitals, and demand for premium minimally invasive spine technologies, while the European Union emphasizes device quality, clinical documentation, post-market surveillance, and compliance under the Medical Device Regulation framework.

BRICS countries combine high patient volume with uneven access, creating opportunities for cost-effective kyphoplasty needles, vertebroplasty access devices, and training-led market development. G7 countries generally lead in procedural standardization, reimbursement maturity, imaging-guided intervention, and clinical evidence adoption, while NATO member states overlap significantly with advanced European and North American procurement systems that prioritize supply resilience, cybersecurity-aligned digital health integration, and regulatory compliance.

Key Country Insights Across Major Demand Centers

The United States remains central to demand due to high procedure volumes, advanced outpatient and hospital-based spine care, and strong adoption of image-guided interventions. Canada follows with publicly funded care pathways and specialized access in major provinces, while Mexico and Brazil show rising demand through private hospital systems and expanding orthopedic, neurosurgical, and interventional radiology capabilities.

In Europe, the United Kingdom, Germany, France, Italy, and Spain benefit from aging populations and established spine care networks, while Russia maintains demand through large hospital systems despite procurement variability. China and India represent high-volume opportunities driven by population scale, osteoporosis burden, and growing specialist capacity; Japan and South Korea benefit from advanced imaging infrastructure and older demographics; Australia maintains stable demand through high-quality tertiary care, fracture management programs, and established minimally invasive procedure pathways.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize needle design that improves procedural control, cement delivery predictability, imaging visibility, and clinician ergonomics. Product portfolios should address both vertebroplasty and kyphoplasty workflows, including compatible cannulas, access systems, balloons, cement delivery tools, and accessories used in vertebral augmentation procedures.

Commercial strategies should combine regulatory readiness, clinical education, and evidence generation. Manufacturers can strengthen competitiveness by supporting fracture liaison programs, offering simulation-based training, building resilient supply chains, improving packaging and sterility assurance, and developing market-specific pricing models for high-growth regions with varied reimbursement and hospital procurement conditions.

Research Methodology and Evidence Base

This executive summary is based on secondary research from publicly available clinical guidelines, regulatory sources, demographic datasets, medical device intelligence, and peer-reviewed literature on osteoporosis, vertebral compression fractures, vertebroplasty, kyphoplasty, and minimally invasive spine procedures. Sources considered include international health agencies, osteoporosis foundations, government statistics, regulatory databases, and recognized clinical publications.

The analysis applies triangulation across disease burden, aging demographics, procedure adoption, healthcare infrastructure, reimbursement maturity, and regional regulatory conditions. Insights are interpreted qualitatively to identify market direction, demand drivers, competitive priorities, and technology shifts relevant to vertebroplasty and kyphoplasty needle manufacturers, without applying market sizing, market share, or forecasting assumptions.

Conclusion and Strategic Outlook

The vertebroplasty and kyphoplasty needles market is positioned for continued relevance as the global burden of osteoporosis-related vertebral compression fractures rises with population aging. Clinical demand is reinforced by the need for minimally invasive spine interventions that can reduce pain, restore mobility, and support faster recovery in appropriately selected patients.

Future differentiation will depend on precision engineering, imaging compatibility, integrated procedure systems, training support, regulatory compliance, and evidence-backed performance. Companies that align product innovation with regional access needs, clinician workflow requirements, and AI-enabled imaging and quality monitoring improvements will be well positioned in the global vertebral augmentation market.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Market Dynamics
  • 4.3.1. Key Drivers
  • 4.3.2. Key Restraints
  • 4.3.3. Key Opportunities
  • 4.3.4. Key Challenges
• 4.4. Porter's Five Forces Analysis
• 4.5. PESTLE Analysis
• 4.6. Market Outlook
  • 4.6.1. Near-Term Market Outlook (0-2 Years)
  • 4.6.2. Medium-Term Market Outlook (3-5 Years)
  • 4.6.3. Long-Term Market Outlook (5-10 Years)
• 4.7. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Vertebroplasty & Kyphoplasty Needles Market, by Product

• 7.1. Kyphoplasty Needle
  • 7.1.1. Balloon Kyphoplasty
  • 7.1.2. Radiofrequency Kyphoplasty
• 7.2. Vertebroplasty Needle
  • 7.2.1. Hydraulic Injection
  • 7.2.2. Manual Injection

8. Vertebroplasty & Kyphoplasty Needles Market, by Material

• 8.1. Nitinol
• 8.2. Stainless Steel
  • 8.2.1. Austenitic
  • 8.2.2. Martensitic
• 8.3. Titanium

9. Vertebroplasty & Kyphoplasty Needles Market, by Needle Tip Type

• 9.1. Beveled Tip
• 9.2. Diamond Tip
• 9.3. Trocar Tip
• 9.4. Blunt Tip

10. Vertebroplasty & Kyphoplasty Needles Market, by Usability

• 10.1. Single-use
• 10.2. Reusable

11. Vertebroplasty & Kyphoplasty Needles Market, by End User

• 11.1. Hospitals
• 11.2. Ambulatory Surgical Centers
• 11.3. Radiology & Interventional Centers
• 11.4. Specialty Spine & Pain Management Clinics

12. Vertebroplasty & Kyphoplasty Needles Market, by Distribution Channel

• 12.1. Online
• 12.2. Offline

13. Vertebroplasty & Kyphoplasty Needles Market, by Region

• 13.1. Asia-Pacific
• 13.2. North America
• 13.3. Latin America
• 13.4. Europe
• 13.5. Middle East
• 13.6. Africa

14. Vertebroplasty & Kyphoplasty Needles Market, by Group

• 14.1. ASEAN
• 14.2. GCC
• 14.3. European Union
• 14.4. BRICS
• 14.5. G7
• 14.6. NATO

15. Vertebroplasty & Kyphoplasty Needles Market, by Country

• 15.1. United States
• 15.2. Canada
• 15.3. Mexico
• 15.4. Brazil
• 15.5. United Kingdom
• 15.6. Germany
• 15.7. France
• 15.8. Russia
• 15.9. Italy
• 15.10. Spain
• 15.11. China
• 15.12. India
• 15.13. Japan
• 15.14. Australia
• 15.15. South Korea

16. Competitive Landscape

• 16.1. Market Concentration Analysis, 2025
  • 16.1.1. Concentration Ratio (CR)
  • 16.1.2. Herfindahl Hirschman Index (HHI)
• 16.2. Recent Developments & Impact Analysis, 2025
• 16.3. Product Portfolio Analysis, 2025
• 16.4. Benchmarking Analysis, 2025

17. Company Profiles

• 17.1. Alphatec Holdings, Inc.
• 17.2. Argon Medical Devices, Inc.
• 17.3. Becton, Dickinson and Company
• 17.4. Biopsybell S.R.L.
• 17.5. Cardinal Health, Inc.
• 17.6. Cook Medical LLC
• 17.7. DePuy Synthes Inc.
• 17.8. G21 S.r.l.
• 17.9. Globus Medical, Inc.
• 17.10. IZI Medical Products, LLC
• 17.11. Johnson & Johnson
• 17.12. Joimax GmbH
• 17.13. Laurane Medical LLC
• 17.14. Medtronic plc
• 17.15. Merit Medical Systems, Inc.
• 17.16. NuVasive, Inc.
• 17.17. Orthofix Medical Inc.
• 17.18. Rontis AG
• 17.19. Shanghai Kinetic Medical Co., Ltd.
• 17.20. Spine Wave, Inc.
• 17.21. Stryker Corporation
• 17.22. Tecres S.p.A.
• 17.23. Teknimed SAS
• 17.24. Zavation Medical Products, LLC
• 17.25. Zimmer Biomet Holdings, Inc.